Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07147192 · ClinicalTrials.gov registry record · NA
Feasibility Study of an Accommodating IOL Design
A NA study of Aphakia, sponsored by Alcon Research.
- Recruiting
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 5
- Study locations
NCT07147192: Recruiting NA study of Aphakia, sponsored by Alcon Research.
NCT07147192 is a NA study of Aphakia that is actively recruiting participants, run by Alcon Research. The registered enrollment target is 85 participants, below the 198-participant average among 5 other Aphakia trials with a reported enrollment target (57% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07147192, a NA study of Aphakia, is actively recruiting participants, sponsored by Alcon Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.
Conditions Studied
Interventions
- PROCEDURE Phacoemulsification
- DEVICE AAL-FAIOL
- DEVICE BAL-FAIOL
Study Locations (5)
Other
- Clinica 20/20 - San José
- Instituto Espaillat Cabral - Santo Domingo
- Centro Panamericano de Ojos / Clinica Lopez Beltran - San Salvador
- Panama Eye Center - Panama City
Texas
- Contact Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT07147192 shows while recruiting
NCT07147192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 198-participant average among 5 other Aphakia trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Aphakia appearing as the primary indexed condition, and to 3 interventions - of which Phacoemulsification is the first listed.
NCT07147192 lists 5 locations in 2 states (Other, Texas).
Frequently Asked Questions
What is clinical trial NCT07147192 about?
NCT07147192 is a clinical study titled "Feasibility Study of an Accommodating IOL Design". The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.
What is the current status of trial NCT07147192?
This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-12-03. Estimated completion is 2027-11.
What conditions does trial NCT07147192 study?
This clinical trial studies the following conditions: Aphakia.
What interventions are being tested in trial NCT07147192?
The interventions under investigation include: Phacoemulsification (PROCEDURE), AAL-FAIOL (DEVICE), BAL-FAIOL (DEVICE).
Who is sponsoring clinical trial NCT07147192?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07147192 being conducted?
This trial has 5 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphakia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clareon Toric vs Eyhance Toric
COMPLETED · NA
-
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
COMPLETED · NA
-
Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI